Click here to get full coverage on Planned share sale by Xencor (XNCR) director under Rule 10b5-1 plan - Stock Titan

Planned share sale by Xencor (XNCR) director under Rule 10b5-1 plan  Stock Titan

Planned share sale by Xencor (XNCR) director under Rule 10b5-1 plan - Stock Titan

Click here to get full coverage on Xencor (XNCR) Stock Draws Fresh Price Target Split As Pipeline Progress Meets Caution - Yahoo Finance

Xencor (XNCR) Stock Draws Fresh Price Target Split As Pipeline Progress Meets Caution  Yahoo Finance

Xencor (XNCR) Stock Draws Fresh Price Target Split As Pipeline Progress Meets Caution - Yahoo Finance

Click here to get full coverage on Xencor (XNCR) director sells 5,474 shares under Rule 10b5-1 plan - Stock Titan

Xencor (XNCR) director sells 5,474 shares under Rule 10b5-1 plan  Stock Titan

Xencor (XNCR) director sells 5,474 shares under Rule 10b5-1 plan - Stock Titan

Click here to get full coverage on Xencor Inc (XNCR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Xencor Inc (XNCR) Earnings Forecast: Future EPS & Revenue Growth Estimates  TradingKey

Xencor Inc (XNCR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Click here to get full coverage on Understanding Momentum Shifts in (XNCR) - Stock Traders Daily

Understanding Momentum Shifts in (XNCR)  Stock Traders Daily

Understanding Momentum Shifts in (XNCR) - Stock Traders Daily

Click here to get full coverage on Xencor (XNCR) director Ranieri sells 5,474 shares under 10b5-1 plan - Stock Titan

Xencor (XNCR) director Ranieri sells 5,474 shares under 10b5-1 plan  Stock Titan

Xencor (XNCR) director Ranieri sells 5,474 shares under 10b5-1 plan - Stock Titan

Click here to get full coverage on Jefferies Financial Group Inc. Purchases 620,440 Shares of Xencor, Inc. $XNCR - MarketBeat

Jefferies Financial Group Inc. Purchases 620,440 Shares of Xencor, Inc. $XNCR  MarketBeat

Jefferies Financial Group Inc. Purchases 620,440 Shares of Xencor, Inc. $XNCR - MarketBeat

Click here to get full coverage on $XNCR stock is up 15% today. Here's what we see in our data. - Quiver Quantitative

$XNCR stock is up 15% today. Here's what we see in our data.  Quiver Quantitative

$XNCR stock is up 15% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Xencor (XNCR): BofA Bullish on US Biopharmaceuticals Coverage - Yahoo Finance

Xencor (XNCR): BofA Bullish on US Biopharmaceuticals Coverage  Yahoo Finance

Xencor (XNCR): BofA Bullish on US Biopharmaceuticals Coverage - Yahoo Finance

Click here to get full coverage on Director at Xencor (XNCR) sells 7,527 shares under 10b5-1 plan - Stock Titan

Director at Xencor (XNCR) sells 7,527 shares under 10b5-1 plan  Stock Titan

Director at Xencor (XNCR) sells 7,527 shares under 10b5-1 plan - Stock Titan

Click here to get full coverage on New Analyst Forecast: $XNCR Given $18.0 Price Target - Quiver Quantitative

New Analyst Forecast: $XNCR Given $18.0 Price Target  Quiver Quantitative

New Analyst Forecast: $XNCR Given $18.0 Price Target - Quiver Quantitative

Click here to get full coverage on These Analysts Think Xencor, Inc.'s (NASDAQ:XNCR) Sales Are Under Threat - Yahoo Finance

These Analysts Think Xencor, Inc.'s (NASDAQ:XNCR) Sales Are Under Threat  Yahoo Finance

These Analysts Think Xencor, Inc.'s (NASDAQ:XNCR) Sales Are Under Threat - Yahoo Finance

Click here to get full coverage on [144] Xencor Inc SEC Filing - Stock Titan

[144] Xencor Inc SEC Filing  Stock Titan

[144] Xencor Inc SEC Filing - Stock Titan

Click here to get full coverage on What Catalysts Are Rewriting The Xencor (XNCR) Story In A Recovering Biopharma Sector - Yahoo Finance

What Catalysts Are Rewriting The Xencor (XNCR) Story In A Recovering Biopharma Sector  Yahoo Finance

What Catalysts Are Rewriting The Xencor (XNCR) Story In A Recovering Biopharma Sector - Yahoo Finance

Click here to get full coverage on Xencor (XNCR) Valuation Check After New Oncology And Autoimmune Pipeline Milestones - Yahoo Finance

Xencor (XNCR) Valuation Check After New Oncology And Autoimmune Pipeline Milestones  Yahoo Finance

Xencor (XNCR) Valuation Check After New Oncology And Autoimmune Pipeline Milestones - Yahoo Finance

Click here to get full coverage on EcoR1 reports 2.9% Xencor stake (NASDAQ: XNCR) - Stock Titan

EcoR1 reports 2.9% Xencor stake (NASDAQ: XNCR)  Stock Titan

EcoR1 reports 2.9% Xencor stake (NASDAQ: XNCR) - Stock Titan

Click here to get full coverage on Executive severance plan at Xencor (NASDAQ: XNCR) adds change-in-control terms - Stock Titan

Executive severance plan at Xencor (NASDAQ: XNCR) adds change-in-control terms  Stock Titan

Executive severance plan at Xencor (NASDAQ: XNCR) adds change-in-control terms - Stock Titan

Click here to get full coverage on Xencor (XNCR) expands TL1A franchise with XmAb942 data and XmAb412 moving to clinic - Stock Titan

Xencor (XNCR) expands TL1A franchise with XmAb942 data and XmAb412 moving to clinic  Stock Titan

Xencor (XNCR) expands TL1A franchise with XmAb942 data and XmAb412 moving to clinic - Stock Titan

Click here to get full coverage on Xencor (NASDAQ: XNCR) Q1 loss widens as revenue and royalties fall - Stock Titan

Xencor (NASDAQ: XNCR) Q1 loss widens as revenue and royalties fall  Stock Titan

Xencor (NASDAQ: XNCR) Q1 loss widens as revenue and royalties fall - Stock Titan

Click here to get full coverage on Could Early XmAb819 Signals Reshape Xencor’s (XNCR) Broader T‑Cell Engager Investment Narrative? - Yahoo Finance

Could Early XmAb819 Signals Reshape Xencor’s (XNCR) Broader T‑Cell Engager Investment Narrative?  Yahoo Finance

Could Early XmAb819 Signals Reshape Xencor’s (XNCR) Broader T‑Cell Engager Investment Narrative? - Yahoo Finance

Click here to get full coverage on Avoiding Lag: Real-Time Signals in (XNCR) Movement - Stock Traders Daily

Avoiding Lag: Real-Time Signals in (XNCR) Movement  Stock Traders Daily

Avoiding Lag: Real-Time Signals in (XNCR) Movement - Stock Traders Daily

Click here to get full coverage on Bank of America Securities Sticks to Their Hold Rating for Xencor (XNCR) - The Globe and Mail

Bank of America Securities Sticks to Their Hold Rating for Xencor (XNCR)  The Globe and Mail

Bank of America Securities Sticks to Their Hold Rating for Xencor (XNCR) - The Globe and Mail

Click here to get full coverage on XNCR: Accelerating clinical data and innovation in bispecifics drive pipeline and commercial focus - TradingView

XNCR: Accelerating clinical data and innovation in bispecifics drive pipeline and commercial focus  TradingView

XNCR: Accelerating clinical data and innovation in bispecifics drive pipeline and commercial focus - TradingView

Click here to get full coverage on Xencor, Inc. (XNCR) Discusses Phase I Results for XmAb942 and Preclinical Data for XmAb412 - Slideshow - Seeking Alpha

Xencor, Inc. (XNCR) Discusses Phase I Results for XmAb942 and Preclinical Data for XmAb412 - Slideshow  Seeking Alpha

Xencor, Inc. (XNCR) Discusses Phase I Results for XmAb942 and Preclinical Data for XmAb412 - Slideshow - Seeking Alpha

Click here to get full coverage on A Look At Xencor (XNCR) Valuation After New XmAb819 Renal Cancer Data And Pipeline Milestone Update - simplywall.st

A Look At Xencor (XNCR) Valuation After New XmAb819 Renal Cancer Data And Pipeline Milestone Update  simplywall.st

A Look At Xencor (XNCR) Valuation After New XmAb819 Renal Cancer Data And Pipeline Milestone Update - simplywall.st

Click here to get full coverage on Is Xencor (XNCR) Now Fairly Priced After Prolonged Share Price Declines - simplywall.st

Is Xencor (XNCR) Now Fairly Priced After Prolonged Share Price Declines  simplywall.st

Is Xencor (XNCR) Now Fairly Priced After Prolonged Share Price Declines - simplywall.st

Click here to get full coverage on Xencor: Fortress Balance Sheet Bodes Well For XmAb819 And XmAb942 (NASDAQ:XNCR) - Seeking Alpha

Xencor: Fortress Balance Sheet Bodes Well For XmAb819 And XmAb942 (NASDAQ:XNCR)  Seeking Alpha

Xencor: Fortress Balance Sheet Bodes Well For XmAb819 And XmAb942 (NASDAQ:XNCR) - Seeking Alpha

Click here to get full coverage on Xencor Announces Change to Ultomiris® Royalty Revenue Forecast - Business Wire

Xencor Announces Change to Ultomiris® Royalty Revenue Forecast  Business Wire

Xencor Announces Change to Ultomiris® Royalty Revenue Forecast - Business Wire

Click here to get full coverage on Xencor Reports First Quarter 2026 Financial Results - Business Wire

Xencor Reports First Quarter 2026 Financial Results  Business Wire

Xencor Reports First Quarter 2026 Financial Results - Business Wire

Click here to get full coverage on BofA Securities Maintains Xencor(XNCR.US) With Hold Rating, Maintains Target Price $17 - Moomoo

BofA Securities Maintains Xencor(XNCR.US) With Hold Rating, Maintains Target Price $17  Moomoo

BofA Securities Maintains Xencor(XNCR.US) With Hold Rating, Maintains Target Price $17 - Moomoo

Click here to get full coverage on These Analysts Just Made A Huge Downgrade To Their Xencor, Inc. (NASDAQ:XNCR) EPS Forecasts - simplywall.st

These Analysts Just Made A Huge Downgrade To Their Xencor, Inc. (NASDAQ:XNCR) EPS Forecasts  simplywall.st

These Analysts Just Made A Huge Downgrade To Their Xencor, Inc. (NASDAQ:XNCR) EPS Forecasts - simplywall.st

Click here to get full coverage on Behavioral Patterns of XNCR and Institutional Flows - Stock Traders Daily

Behavioral Patterns of XNCR and Institutional Flows  Stock Traders Daily

Behavioral Patterns of XNCR and Institutional Flows - Stock Traders Daily

Click here to get full coverage on Xencor to Host Webcast to Discuss XmAb942 and XmAb412 Data Presentations at DDW - Business Wire

Xencor to Host Webcast to Discuss XmAb942 and XmAb412 Data Presentations at DDW  Business Wire

Xencor to Host Webcast to Discuss XmAb942 and XmAb412 Data Presentations at DDW - Business Wire

Click here to get full coverage on BofA Securities Maintains Xencor(XNCR.US) With Hold Rating, Cuts Target Price to $19 - Moomoo

BofA Securities Maintains Xencor(XNCR.US) With Hold Rating, Cuts Target Price to $19  Moomoo

BofA Securities Maintains Xencor(XNCR.US) With Hold Rating, Cuts Target Price to $19 - Moomoo

Click here to get full coverage on What Xencor (XNCR)'s 2026 XmAb Pivotal Plans and Cash Runway Through 2028 Mean For Shareholders - simplywall.st

What Xencor (XNCR)'s 2026 XmAb Pivotal Plans and Cash Runway Through 2028 Mean For Shareholders  simplywall.st

What Xencor (XNCR)'s 2026 XmAb Pivotal Plans and Cash Runway Through 2028 Mean For Shareholders - simplywall.st

Click here to get full coverage on (XNCR) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

(XNCR) Movement Within Algorithmic Entry Frameworks  Stock Traders Daily

(XNCR) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Click here to get full coverage on $XNCR stock is up 10% today. Here's what we see in our data. - Quiver Quantitative

$XNCR stock is up 10% today. Here's what we see in our data.  Quiver Quantitative

$XNCR stock is up 10% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Xencor presents Phase 1 XmAb942 final results; XmAb412 FIH study on track for 3Q26 - TradingView

Xencor presents Phase 1 XmAb942 final results; XmAb412 FIH study on track for 3Q26  TradingView

Xencor presents Phase 1 XmAb942 final results; XmAb412 FIH study on track for 3Q26 - TradingView

Click here to get full coverage on Xencor to Participate at Upcoming Investor Conferences - Business Wire

Xencor to Participate at Upcoming Investor Conferences  Business Wire

Xencor to Participate at Upcoming Investor Conferences - Business Wire

Click here to get full coverage on symbol__ Stock Quote Price and Forecast - CNN

symbol__ Stock Quote Price and Forecast  CNN

symbol__ Stock Quote Price and Forecast - CNN

Click here to get full coverage on Xencor Highlights Corporate Priorities and 2026 Pipeline Milestones - Business Wire

Xencor Highlights Corporate Priorities and 2026 Pipeline Milestones  Business Wire

Xencor Highlights Corporate Priorities and 2026 Pipeline Milestones - Business Wire

Click here to get full coverage on Xencor Reports Fourth Quarter and Full Year 2025 Financial Results - Business Wire

Xencor Reports Fourth Quarter and Full Year 2025 Financial Results  Business Wire

Xencor Reports Fourth Quarter and Full Year 2025 Financial Results - Business Wire

Click here to get full coverage on Xencor Announces Extension of U.S. Patent Term on Certain Xtend™ Antibodies - Business Wire

Xencor Announces Extension of U.S. Patent Term on Certain Xtend™ Antibodies  Business Wire

Xencor Announces Extension of U.S. Patent Term on Certain Xtend™ Antibodies - Business Wire

Click here to get full coverage on Xencor CFO Cornelissen sells $42990 in stock - Investing.com

Xencor CFO Cornelissen sells $42990 in stock  Investing.com

Xencor CFO Cornelissen sells $42990 in stock - Investing.com

Click here to get full coverage on Xencor Inc Stock (US98401F1057): Analyst Views In Focus After Recent Collaboration Momentum - AD HOC NEWS

Xencor Inc Stock (US98401F1057): Analyst Views In Focus After Recent Collaboration Momentum  AD HOC NEWS

Xencor Inc Stock (US98401F1057): Analyst Views In Focus After Recent Collaboration Momentum - AD HOC NEWS

Click here to get full coverage on Caris Life Sciences and Xencor Expand Target Discovery Collaboration for Novel XmAb® Antibody Drug Candidates - PR Newswire

Caris Life Sciences and Xencor Expand Target Discovery Collaboration for Novel XmAb® Antibody Drug Candidates  PR Newswire

Caris Life Sciences and Xencor Expand Target Discovery Collaboration for Novel XmAb® Antibody Drug Candidates - PR Newswire

Click here to get full coverage on Xencor (XNCR) Stock Forecast and Price Target 2026 - MarketBeat

Xencor (XNCR) Stock Forecast and Price Target 2026  MarketBeat

Xencor (XNCR) Stock Forecast and Price Target 2026 - MarketBeat

Click here to get full coverage on Xencor Inc stock (US98401F1057): shares react to Monjuvi first-line lymphoma update and recent Q1 20 - AD HOC NEWS

Xencor Inc stock (US98401F1057): shares react to Monjuvi first-line lymphoma update and recent Q1 20  AD HOC NEWS

Xencor Inc stock (US98401F1057): shares react to Monjuvi first-line lymphoma update and recent Q1 20 - AD HOC NEWS

Click here to get full coverage on Xencor Inc stock (US98401F1057): JPMorgan lifts target while investors eye Q1 2026 update - AD HOC NEWS

Xencor Inc stock (US98401F1057): JPMorgan lifts target while investors eye Q1 2026 update  AD HOC NEWS

Xencor Inc stock (US98401F1057): JPMorgan lifts target while investors eye Q1 2026 update - AD HOC NEWS

Click here to get full coverage on Xencor to Present at Two Major Healthcare Investor Conferences in December - Stock Titan

Xencor to Present at Two Major Healthcare Investor Conferences in December  Stock Titan

Xencor to Present at Two Major Healthcare Investor Conferences in December - Stock Titan

Click here to get full coverage on What is the current Price Target and Forecast for Xencor (XNCR) - Zacks Investment Research

What is the current Price Target and Forecast for Xencor (XNCR)  Zacks Investment Research

What is the current Price Target and Forecast for Xencor (XNCR) - Zacks Investment Research

Click here to get full coverage on Xencor stock (US98401F1057): Biotech focus on immunotherapy and protein engineering - AD HOC NEWS

Xencor stock (US98401F1057): Biotech focus on immunotherapy and protein engineering  AD HOC NEWS

Xencor stock (US98401F1057): Biotech focus on immunotherapy and protein engineering - AD HOC NEWS

Click here to get full coverage on Xencor Inc stock (US98401F1057): shares trade around recent lows as investors digest pipeline and va - AD HOC NEWS

Xencor Inc stock (US98401F1057): shares trade around recent lows as investors digest pipeline and va  AD HOC NEWS

Xencor Inc stock (US98401F1057): shares trade around recent lows as investors digest pipeline and va - AD HOC NEWS

Click here to get full coverage on What date does Xencor's (XNCR) report Earnings - Earnings Calendar & Announcement - Zacks Investment Research

What date does Xencor's (XNCR) report Earnings - Earnings Calendar & Announcement  Zacks Investment Research

What date does Xencor's (XNCR) report Earnings - Earnings Calendar & Announcement - Zacks Investment Research

Click here to get full coverage on XNCR Forecast — Price Target — Prediction for 2027 - TradingView

XNCR Forecast — Price Target — Prediction for 2027  TradingView

XNCR Forecast — Price Target — Prediction for 2027 - TradingView

Click here to get full coverage on XNCR Stock Price | Analyst Target 24.00 & Moderate Buy Consensus - eToro

XNCR Stock Price | Analyst Target 24.00 & Moderate Buy Consensus  eToro

XNCR Stock Price | Analyst Target 24.00 & Moderate Buy Consensus - eToro

Click here to get full coverage on XNCR Stock Price and Chart — NASDAQ:XNCR - TradingView

XNCR Stock Price and Chart — NASDAQ:XNCR  TradingView

XNCR Stock Price and Chart — NASDAQ:XNCR - TradingView

Click here to get full coverage on Xencor stock touches 52-week low at $12.53 amid market challenges - Investing.com

Xencor stock touches 52-week low at $12.53 amid market challenges  Investing.com

Xencor stock touches 52-week low at $12.53 amid market challenges - Investing.com

Click here to get full coverage on Xencor (XNCR) - Zacks Investment Research

Xencor (XNCR)  Zacks Investment Research

Xencor (XNCR) - Zacks Investment Research

Click here to get full coverage on Technical Analysis of Xencor, Inc. (NASDAQ:XNCR) - TradingView

Technical Analysis of Xencor, Inc. (NASDAQ:XNCR)  TradingView

Technical Analysis of Xencor, Inc. (NASDAQ:XNCR) - TradingView

Click here to get full coverage on Top Xencor (XNCR) Competitors 2026 - MarketBeat

Top Xencor (XNCR) Competitors 2026  MarketBeat

Top Xencor (XNCR) Competitors 2026 - MarketBeat

Click here to get full coverage on Should I buy Xencor (XNCR) - Zacks Investment Research

Should I buy Xencor (XNCR)  Zacks Investment Research

Should I buy Xencor (XNCR) - Zacks Investment Research

Click here to get full coverage on Ronin Trading, Llc Net Worth (2026) - GuruFocus

Ronin Trading, Llc Net Worth (2026)  GuruFocus

Ronin Trading, Llc Net Worth (2026) - GuruFocus

Click here to get full coverage on Xencor (XNCR) Stock Price, News & Analysis - MarketBeat

Xencor (XNCR) Stock Price, News & Analysis  MarketBeat

Xencor (XNCR) Stock Price, News & Analysis - MarketBeat

Click here to get full coverage on Jonathan Fleming Net Worth (2026) - GuruFocus

Jonathan Fleming Net Worth (2026)  GuruFocus

Jonathan Fleming Net Worth (2026) - GuruFocus

Click here to get full coverage on XNCR Q1 2026 Earnings: Wider-than-Expected Loss as Pipeline Progress Continues - Quarterly Earnings - newsline.com

XNCR Q1 2026 Earnings: Wider-than-Expected Loss as Pipeline Progress Continues - Quarterly Earnings  newsline.com

XNCR Q1 2026 Earnings: Wider-than-Expected Loss as Pipeline Progress Continues - Quarterly Earnings - newsline.com

Click here to get full coverage on XNCR Q1 2026 Earnings: Wider-than-Expected Loss as Pipeline Progress Continues - Weak Earnings Momentum - newsline.com

XNCR Q1 2026 Earnings: Wider-than-Expected Loss as Pipeline Progress Continues - Weak Earnings Momentum  newsline.com

XNCR

Price Chart

Key Statistics

Technicals

About XNCR

Latest News

Planned share sale by Xencor (XNCR) director under Rule 10b5-1 plan - Stock Titan

Xencor (XNCR) Stock Draws Fresh Price Target Split As Pipeline Progress Meets Caution - Yahoo Finance

Xencor (XNCR) director sells 5,474 shares under Rule 10b5-1 plan - Stock Titan

Advanced Charts

Top Gainers

Top Losers